Special Issue "Cancer Biomarker: Current Status and Future Perspectives"

Area of Science:

• Biomarker Discovery
• Molecular Biology
• Omics Technologies

Background:

• Recent advancements in omics technologies have accelerated biomarker identification.
• Diverse molecular data types are utilized, including DNA, RNA, microRNAs (miRNAs), and long non-coding RNAs.
• Proteomic, metabolic, and lipidomic alterations are also key areas of investigation.

Discussion:

• Omics technologies provide a comprehensive view of biological systems.
• The integration of multi-omics data enhances biomarker discovery and validation.
• Understanding these molecular signatures is crucial for disease diagnosis and prognosis.

Key Insights:

• DNA, RNA, miRNA, lncRNA, protein, and metabolite alterations serve as valuable biomarkers.
• High-throughput omics platforms enable large-scale biomarker profiling.
• These biomarkers have potential applications in precision medicine and diagnostics.

Outlook:

• Future research will focus on integrating multi-omics data for more robust biomarker panels.
• Clinical translation of omics-based biomarkers is expected to increase.
• Continued technological innovation will further expand the scope of biomarker discovery.